美国生物医药产业政策及启示  

American Bio-pharmaceutical Industry Policy and its Enlightenment

作　　者：洪兰[1] 李野[1] 何文威[1] 

机构地区：[1]沈阳药科大学工商管理学院,沈阳市110016

出　　处：《中国药房》2005年第23期1771-1773,共3页China Pharmacy

摘　　要：目的:为促进我国生物医药产业发展提供参考。方法:分析美国生物医药产业发展概况,研究并吸取其先进的生物医药产业政策经验。结果与结论:生物医药产业政策是促进生物医药产业快速发展的重要保障。我国可以在借鉴先进经验的基础上结合实际,更好地制订适合我国国情的生物医药产业发展政策。OBJECTIVE： To provide references for promoting the development of Chinese bio- pharmaceutical industry. METHODS： The development of American bio - pharmaceutical industry was analyzed, and their advanced experiences on bio- pharmaceutical industry policy were investigated and drawn. RESULTS ＆ CONCLUSION ： Bio- pharmaceutical industry policy is essential in ensuring fast development of bio- pharmaceutical industry. Based on the advanced experiences drawn from American, together with the practicality, we should formulate bio- pharmaceutical industry development policy that tailored to our own specific condition.

关 键 词：美国 生物医药 产业政策 启示 

分 类 号：R95[医药卫生—药学]